Alzheimer's disease (AD) is a heterogeneous disease with different subtypes. Studying AD
subtypes from brain structure, neuropathology, and cognition are of great importance for AD …

Accumulating evidence suggests that Alzheimer's disease (AD) is heterogenous and can be
classified into several subtypes. Here, we propose a robust subtyping method for AD based …

There is increasing evidence showing that brain atrophy varies between patients with
Alzheimer's disease (AD), suggesting that different anatomical patterns might exist within the …

We aimed to identify and characterize subtypes of Alzheimer's disease (AD) exhibiting
different patterns of regional brain atrophy on MRI using age-and gender-specific norms of …

Atrophy patterns on MRI can reliably predict three neuropathological subtypes of
Alzheimer's disease (AD): typical, limbic-predominant, or hippocampal-sparing. A method to …

Alzheimer's disease is a heterogeneous disorder. Understanding the biological basis for this
heterogeneity is key for developing personalized medicine. We identified atrophy subtypes …

Biological subtypes in Alzheimer's disease, originally identified on neuropathological data,
have been translated to in vivo biomarkers such as structural magnetic resonance imaging …

Alzheimer's disease (AD) is a disease of a heterogeneous nature, which can be
disentangled by exploring the characteristics of each AD subtype in the brain structure …

Objective To test the hypothesis that distinct subtypes of Alzheimer disease (AD) exist and
underlie the heterogeneity within AD, we conducted a systematic review and meta-analysis …

Alzheimer's disease (AD) is a complex form of dementia and due to its high phenotypic
variability, its diagnosis and monitoring can be quite challenging. Biomarkers play a crucial …